@qz.com 17 days ago Off-brand weight-loss drug makers are suing the FDA, again
@qz.com 3 months ago Nestle's GLP-1 'shot,' the FDA's Zepbound ruling, and Ozempic lures people to the doctor: Pharma news roundup
@qz.com 8 months ago Pfizer's weight loss pill, FDA rejects Novo's weekly insulin, and FTC says drug middlemen are hiking prices: Pharma news round up
@fastcompany.com a year ago Ozempic is not going to slim down your stock portfolio (yet)